ABVC BioPharma, Inc. Stockholders' Equity Note, Subscriptions Receivable
ABVC BioPharma, Inc. (ABVC) had Stockholders' Equity Note, Subscriptions Receivable of $225.74 thousand as of 2024-03-31, per its 10-Q filed 2024-05-17.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquityNoteSubscriptionsReceivable · last filed 2026-03-03
- 2024-03-31: Stockholders' Equity Note, Subscriptions Receivable $225.74K.
- 2023-12-31: Stockholders' Equity Note, Subscriptions Receivable $451.48K.
- 2023-09-30: Stockholders' Equity Note, Subscriptions Receivable $677.22K.
- 2023-06-30: Stockholders' Equity Note, Subscriptions Receivable $902.96K.
| Period end | Stockholders' Equity Note, Subscriptions Receivable |
|---|---|
| 2024-03-31 | $225.74K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $451.48K 10-Q · filed 2024-11-14 |
| 2023-09-30 | $677.22K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $902.96K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.13M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.35M 10-Q/A · filed 2026-03-03 |
| 2022-09-30 | $1.58M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.81M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.03M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.26M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.48M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.71M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.93M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.16M 10-K · filed 2022-03-31 |
| 2020-09-30 | $3.39M 10-Q · filed 2020-11-17 |
| 2020-06-30 | $3.61M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.84M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $4.06M 10-K · filed 2021-03-16 |
| 2019-09-30 | $4.29M 10-Q · filed 2019-11-18 |